Telemedicine in Ophthalmology — MCQs
Which of the following attributes are essential for an ideal screening test?
In open-angle glaucoma, which investigation is least useful for diagnosis?
Under Vision 2020, to check visual acuity, a teacher will refer a school child to
Match the following drugs in Column A with their contraindications in Column B. | Column A | Column B | | :-- | :-- | | 1. Morphine | 1. QT prolongation | | 2. Amiodarone | 2. Thromboembolism | | 3. Vigabatrin | 3. Pregnancy | | 4. Estrogen preparations | 4. Head injury |
Fluorescein dye for ophthalmological diagnosis is injected into:
Statement 1 - A 59-year-old patient presents with flaccid bullae. Histopathology shows a suprabasal acantholytic split. Statement 2 - The row of tombstones appearance is diagnostic of Pemphigus vulgaris.
A patient with ptosis has the upper 4 mm of cornea covered by the upper eyelid. What is the grade of ptosis?
Xerophthalmia is considered a problem in a community if:
Which of the following is not included in the SAFE strategy?
Who is the chairman of the district blindness control society?
Telemedicine in Ophthalmology Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following attributes are essential for an ideal screening test?
- A. Safe
- B. Reliable
- C. Valid
- D. All of the options (Correct Answer)
Explanation: ***All of the options*** - An ideal screening test must possess **all three essential attributes**: safety, reliability, and validity. - **Safe**: Minimizes harm to participants and ensures ethical implementation - **Reliable**: Produces consistent, reproducible results with minimal random error - **Valid**: Accurately measures what it intends to measure (high sensitivity and specificity) - These three attributes work together as fundamental requirements for any effective screening program, ensuring that early detection benefits outweigh potential risks. *Safe (alone)* - While safety is absolutely essential, it is **not sufficient by itself** to make an ideal screening test. - A test that is safe but unreliable or invalid would produce inconsistent or inaccurate results, rendering it ineffective for screening purposes. *Reliable (alone)* - Reliability ensures consistent results, which is crucial, but **reliability alone is insufficient**. - A test can be highly reliable (consistently giving the same result) yet completely invalid if it measures the wrong thing or is unsafe. *Valid (alone)* - Validity is critical for accurate measurement, but **validity alone does not make a test ideal**. - Even a valid test must be safe to protect participants and reliable to ensure consistency across different settings and times.
Question 2: In open-angle glaucoma, which investigation is least useful for diagnosis?
- A. Indirect ophthalmoscopy (Correct Answer)
- B. Tonometry
- C. Direct ophthalmoscopy
- D. Perimetry
Explanation: ***Indirect ophthalmoscopy*** - While useful for viewing the peripheral retina, **indirect ophthalmoscopy** is less effective than other methods for assessing the optic nerve head and retinal nerve fiber layer changes characteristic of open-angle glaucoma. - Its primary utility is for detecting **retinal detachment** or other peripheral retinal pathologies, which are not directly diagnostic of glaucoma. *Tonometry* - **Tonometry** measures the intraocular pressure (IOP), a primary risk factor for open-angle glaucoma, and is essential for monitoring treatment effectiveness. - Elevated IOP is a key indicator, though not always present, and normal-tension glaucoma exists. *Direct ophthalmoscopy* - **Direct ophthalmoscopy** allows for visualization of the optic nerve head, enabling detection of characteristic glaucoma changes such as **cupping** and loss of the neuroretinal rim. - This method is crucial for assessing **optic nerve damage**, a hallmark of glaucoma. *Perimetry* - **Perimetry**, or visual field testing, assesses the functional impact of glaucoma by detecting **peripheral vision loss**. - This test identifies specific patterns of visual field defects that correlate with nerve fiber layer damage and is vital for staging and monitoring disease progression.
Question 3: Under Vision 2020, to check visual acuity, a teacher will refer a school child to
- A. Centre for excellence
- B. Vision centre (Correct Answer)
- C. Training centre
- D. Service centre
Explanation: ***Vision centre*** - Under Vision 2020 initiatives, a **Vision Centre** serves as the primary point of contact for basic ophthalmic services, including **visual acuity screening** and referral. - These centers are designed to be accessible in local communities, allowing teachers and other local caregivers to refer school children for initial checks and appropriate management. *Centre for excellence* - A **Centre for Excellence** typically refers to a highly specialized institution with advanced diagnostic and treatment capabilities, research facilities, and complex surgical procedures, which is **beyond the scope** of basic visual acuity checking and initial referral. - Such centers handle more **complex or rare conditions** and are not the first point of contact for routine school-based screening. *Training centre* - A **Training Centre** is primarily dedicated to educating and skilling healthcare professionals, not to providing direct patient care or screening services to the general public. - While essential for developing skilled personnel, it is **not the appropriate facility** for a teacher to refer a child for a visual acuity check. *Service centre* - The term **Service Centre** is too broad and can refer to various types of facilities that provide any kind of service, but it does not specifically denote a healthcare facility for ophthalmic care under the Vision 2020 program. - It lacks the **specific medical context** and structured role established for vision screening.
Question 4: Match the following drugs in Column A with their contraindications in Column B. | Column A | Column B | | :-- | :-- | | 1. Morphine | 1. QT prolongation | | 2. Amiodarone | 2. Thromboembolism | | 3. Vigabatrin | 3. Pregnancy | | 4. Estrogen preparations | 4. Head injury |
- A. A-1, B-3, C-2, D-4
- B. A-4, B-1, C-3, D-2 (Correct Answer)
- C. A-3, B-2, C-4, D-1
- D. A-2, B-4, C-1, D-3
Explanation: ***A-4, B-1, C-3, D-2*** - **Morphine** is contraindicated in **head injury** as it can increase intracranial pressure and mask neurological symptoms. - **Amiodarone** is contraindicated in patients with **QT prolongation** due to its risk of inducing more severe arrhythmias like Torsades de Pointes. - **Vigabatrin** is contraindicated during **pregnancy** due to its potential for teratogenicity and adverse effects on fetal development. - **Estrogen preparations** are contraindicated in patients with a history of **thromboembolism** due to their increased risk of blood clot formation. *A-1, B-3, C-2, D-4* - This option incorrectly matches **Morphine** with QT prolongation and **Estrogen preparations** with head injury, which are not their primary contraindications. - It also incorrectly links **Vigabatrin** with thromboembolism and **Amiodarone** with pregnancy. *A-3, B-2, C-4, D-1* - This choice incorrectly associates **Morphine** with pregnancy and **Vigabatrin** with head injury, which are not the most critical or direct contraindications. - It also misaligns **Amiodarone** with thromboembolism and **Estrogen preparations** with QT prolongation. *A-2, B-4, C-1, D-3* - This option incorrectly matches **Morphine** with thromboembolism and **Amiodarone** with head injury, which are not their most significant contraindications. - It also incorrectly links **Vigabatrin** with QT prolongation and **Estrogen preparations** with pregnancy.
Question 5: Fluorescein dye for ophthalmological diagnosis is injected into:
- A. Antecubital vein (Correct Answer)
- B. Popliteal vein
- C. Femoral vein
- D. Subclavian vein
Explanation: ***Antecubital vein*** - Fluorescein angiography requires rapid delivery of the dye into the **systemic circulation** for quick visualization of retinal and choroidal vasculature. - The **antecubital vein** is a readily accessible, large superficial vein that allows for quick and efficient intravenous dye injection. *Popliteal vein* - The popliteal vein is located behind the **knee** and is not a standard or practical site for routine intravenous injections, especially when rapid delivery to the eye is needed. - Its location makes it less accessible and potentially more uncomfortable for the patient compared to an arm vein. *Femoral vein* - The femoral vein is a large, deep vein in the **groin**, typically reserved for central venous access or specific procedures due to the increased risk of complications like infection or hematoma. - It is not routinely used for peripheral intravenous injections such as fluorescein, where a more superficial and accessible vein is preferred. *Subclavian vein* - The subclavian vein is a **central vein** located under the clavicle, accessed via a more invasive procedure, usually for central venous catheters or hemodialysis access. - It carries higher risks compared to peripheral venipuncture and is not chosen for simple diagnostic dye injections like fluorescein.
Question 6: Statement 1 - A 59-year-old patient presents with flaccid bullae. Histopathology shows a suprabasal acantholytic split. Statement 2 - The row of tombstones appearance is diagnostic of Pemphigus vulgaris.
- A. Statements 1 & 2 are correct, 2 is not explaining 1 (Correct Answer)
- B. Statements 1 and 2 are correct and 2 is the correct explanation for 1
- C. Statements 1 and 2 are incorrect
- D. Statement 1 is incorrect
Explanation: ***Correct: Statements 1 & 2 are correct, 2 is not explaining 1*** **Analysis of Statement 1:** - A 59-year-old patient with **flaccid bullae** and **suprabasal acantholytic split** on histopathology is the classic presentation of **Pemphigus vulgaris** - The flaccid (easily ruptured) nature of bullae distinguishes it from tense bullae seen in bullous pemphigoid - The suprabasal location of the split (just above the basal layer) with acantholysis (loss of cell-to-cell adhesion) is pathognomonic - **Statement 1 is CORRECT** ✓ **Analysis of Statement 2:** - The **"row of tombstones" or "tombstone appearance"** is indeed a diagnostic histopathological feature of Pemphigus vulgaris - This appearance results from basal keratinocytes remaining attached to the basement membrane while suprabasal cells separate due to acantholysis - The intact basal cells standing upright resemble a row of tombstones - **Statement 2 is CORRECT** ✓ **Does Statement 2 explain Statement 1?** - Statement 2 describes a **histopathological appearance** (tombstone pattern) that is a **consequence** of the suprabasal split - However, it does NOT explain the **underlying cause** of the flaccid bullae or the suprabasal split - The true explanation involves **IgG autoantibodies against desmoglein 3 (and desmoglein 1)**, which attack intercellular adhesion structures (desmosomes), causing **acantholysis** - Therefore, **Statement 2 does NOT explain Statement 1** ✗ *Incorrect: Statement 2 is the correct explanation for Statement 1* - While both statements describe features of Pemphigus vulgaris, the tombstone appearance is a descriptive finding, not an explanatory mechanism *Incorrect: Statements 1 and 2 are incorrect* - Both statements are medically accurate descriptions of Pemphigus vulgaris features *Incorrect: Statement 1 is incorrect* - Statement 1 correctly describes the cardinal clinical and histopathological features of Pemphigus vulgaris
Question 7: A patient with ptosis has the upper 4 mm of cornea covered by the upper eyelid. What is the grade of ptosis?
- A. Moderate (Correct Answer)
- B. Profound
- C. Severe
- D. Mild
Explanation: ***Moderate*** - **Moderate ptosis** is defined as **3-4 mm of lid drooping** below the normal position - In this case, the upper eyelid covers **4 mm of the cornea**, which falls into the moderate category - The lid margin is typically **at or slightly below the superior limbus** in moderate ptosis - This degree of ptosis is **functionally significant** and may warrant surgical correction *Mild* - **Mild ptosis** is defined as **2 mm or less** of lid drooping - The upper lid margin is **above the superior limbus** but below the normal position - This patient has 4 mm coverage, which **exceeds the mild category** *Severe* - **Severe ptosis** is defined as **5 mm or more** of lid drooping below the normal position - The upper lid typically **covers the pupillary axis significantly** and causes marked visual obstruction - This patient's 4 mm coverage **does not reach severe criteria** *Profound* - **"Profound"** is not a standard term in ptosis grading systems - The standard classification uses **mild, moderate, and severe** as the three grades - If used, it would refer to extreme cases where the lid almost completely covers the pupil
Question 8: Xerophthalmia is considered a problem in a community if:
- A. Night blindness >1% (Correct Answer)
- B. Bitot spots >1%
- C. Corneal ulceration >0.05%
- D. Corneal scarring >0.5%
Explanation: **Explanation:** Vitamin A deficiency (VAD) is a major public health concern in developing nations. To determine if Xerophthalmia constitutes a "public health problem" in a community, the World Health Organization (WHO) has established specific prevalence criteria for children aged 6 months to 6 years. **Why Option A is Correct:** Night blindness (X1N) is the earliest clinical symptom of Vitamin A deficiency. According to WHO criteria, if the prevalence of night blindness in a community exceeds **1%**, it is considered a significant public health problem. This threshold is a high-yield fact for NEET-PG as it represents the primary screening indicator. **Analysis of Incorrect Options:** * **B. Bitot spots >1%:** This is incorrect because the WHO threshold for Bitot spots (X1B) is actually **>0.5%**. * **C. Corneal ulceration >0.05%:** This is incorrect because the threshold for active corneal lesions (X2, X3A, X3B) is **>0.01%**. * **D. Corneal scarring >0.5%:** This is incorrect because the threshold for Xerophthalmia-related corneal scars (XS) is **>0.05%**. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Classification (Xerophthalmia):** * X1N: Night blindness * X1B: Bitot’s spots * X2: Conjunctival xerosis * X3A: Corneal xerosis * X3B: Keratomalacia (involving >1/3rd of the cornea) * XS: Corneal scar * XF: Xerophthalmic fundus * **Biochemical Criteria:** Serum retinol levels **<10 μg/dl (0.35 μmol/L)** in >5% of the population also signifies a public health problem. * **Prophylaxis:** Under the National Vitamin A Prophylaxis Program, the first dose (1 lakh IU) is given at 9 months (with Measles vaccine), followed by 2 lakh IU every 6 months until age 5 (Total 9 doses/17 lakh IU).
Question 9: Which of the following is not included in the SAFE strategy?
- A. Surveillance (Correct Answer)
- B. Antibiotics
- C. Facial hygiene
- D. Environmental modification
Explanation: The **SAFE strategy** is a comprehensive public health approach recommended by the World Health Organization (WHO) for the elimination of **Trachoma** (caused by *Chlamydia trachomatis*) as a public health problem. ### **Why "Surveillance" is the Correct Answer** While surveillance is a general epidemiological principle, it is **not** one of the four specific pillars of the SAFE acronym. The strategy focuses on active intervention and prevention rather than just monitoring. ### **Explanation of the SAFE Components (Incorrect Options)** The acronym **SAFE** stands for: * **S – Surgery:** To treat the blinding stage of the disease (**Trachomatous Trichiasis**). * **A – Antibiotics:** To treat the active infection and reduce the community reservoir. The drug of choice is a single dose of **Azithromycin** (20 mg/kg up to 1g) or Tetracycline eye ointment. * **F – Facial hygiene:** To reduce transmission from eye and nasal secretions, especially in children. * **E – Environmental modification:** Improving access to water and sanitation (e.g., latrine construction) to reduce the breeding of **Musca sorbens** (the eye-seeking fly that acts as a vector). ### **High-Yield Clinical Pearls for NEET-PG** * **Trachoma Classification:** The WHO uses the **FISTO** classification (Follicular, Intense, Scarring, Trichiasis, Opacity). * **Target:** The goal of the Global Elimination of Trachoma (GET2020) was to eliminate trachoma by 2020; India was declared free of "infective trachoma" in 2017. * **Vector:** *Musca sorbens* is the primary fly vector involved in transmission. * **Surgery Type:** The preferred surgical procedure for trichiasis is **Bilamellar Tarsal Rotation (BTR)**.
Question 10: Who is the chairman of the district blindness control society?
- A. District collector (Correct Answer)
- B. Programme manager
- C. District health officer
- D. District eye surgeon
Explanation: ### Explanation The **District Blindness Control Society (DBCS)** is the decentralized implementation unit of the **National Programme for Control of Blindness and Visual Impairment (NPCBVI)**. **1. Why the District Collector is correct:** The District Collector (or District Magistrate) serves as the **Chairman** of the DBCS. This is a strategic administrative decision because blindness control requires inter-sectoral coordination between health, education, and social welfare departments. An administrative head ensures better resource mobilization, financial oversight, and accountability of the program at the district level. **2. Why the other options are incorrect:** * **Programme Manager:** Usually a senior eye surgeon or health official who handles the day-to-day operations and technical execution, but does not hold the chair. * **District Health Officer (CMO/CDMO):** Typically serves as the **Vice-Chairman** or Member Secretary. While they oversee the medical aspects, they report to the Collector for administrative approvals. * **District Eye Surgeon:** Acts as the **Member Secretary** or technical lead. They are responsible for the clinical quality of surgeries and organizing screening camps. **3. High-Yield Clinical Pearls for NEET-PG:** * **NPCBVI Goal:** To reduce the prevalence of blindness to **0.25%** by 2025 (Current prevalence is approx. 0.36% as per 2015-19 survey). * **Definition of Blindness (NPCBVI):** Visual acuity **<3/60** in the better eye with best possible correction. * **Funding:** The DBCS receives grants-in-aid directly from the State Health Society to ensure a "bottom-up" approach. * **Main Cause of Blindness in India:** Cataract (approx. 66%), followed by Refractive Errors.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free